1997
DOI: 10.1016/s0142-9612(96)00131-7
|View full text |Cite
|
Sign up to set email alerts
|

Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
47
0
1

Year Published

1999
1999
2011
2011

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 77 publications
(49 citation statements)
references
References 15 publications
1
47
0
1
Order By: Relevance
“…Microsphere formulations of these polymers have shown promising results in the delivery of many bioactive drugs and proteins (15,18,27). Chitosan, a naturally occurring polysaccharide, is widely used in biomedical applications and is capable of being processed under mild conditions (8,11,12,20). However, the development of a co-matrix system based on these polymers for delivering drug combinations has not been reported.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Microsphere formulations of these polymers have shown promising results in the delivery of many bioactive drugs and proteins (15,18,27). Chitosan, a naturally occurring polysaccharide, is widely used in biomedical applications and is capable of being processed under mild conditions (8,11,12,20). However, the development of a co-matrix system based on these polymers for delivering drug combinations has not been reported.…”
Section: Discussionmentioning
confidence: 99%
“…The studies with drug-loaded chitosan lms and beads proposed that the rate limiting step in drug release was diffusion through the polymer backbone absorbed with water rather than degradation of the polymer (11,13). A similar mechanism of heparin release from chitosan bead is possible in the present system.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…At the same time, the compositions of chitosan with synthetic polymers are used as polymeric carriers; for example, a composite matrix of chitosan-poly(vinyl acetate) can be used as a carrier for aspirin-heparin drug system [50].…”
Section: Cellulose Chitin and Chitosan Blends With Synthetic Polymersmentioning
confidence: 99%